QQ客服 官方微博 反馈留言

	Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens
	Bai, Ju; Wang, Jianli; Yang, Yun; Zhang, Wanggang; Wang, Fangxia; Zhang, Lei; Chen, Hongli; Wang, Xiaman; Feng, Yuandong; Shen, Ying
刊名	HEMATOLOGY
	2019
卷号	24页码:387-391
关键词	prognostic factor response multiple myeloma Serum platelet factor 4
ISSN号	1024-5332
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2826763
专题	西安交通大学
推荐引用方式 GB/T 7714	Bai, Ju,Wang, Jianli,Yang, Yun,et al. Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens[J]. HEMATOLOGY,2019,24:387-391.
APA	Bai, Ju.,Wang, Jianli.,Yang, Yun.,Zhang, Wanggang.,Wang, Fangxia.,...&He, Aili.(2019).Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens.HEMATOLOGY,24,387-391.
MLA	Bai, Ju,et al."Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens".HEMATOLOGY 24(2019):387-391.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。